Login
EN
[EN] English
[FR] Français
Login
EN
[EN] English
[FR] Français
Give us feedback
Explore
Search
Special collections
Statistics
News
Help
Start on ORBi
Deposit
Profile
Publication List
Add your ORCID
Tutorials
Legal Information
Training sessions
About
What's ORBi ?
Impact and visibility
Around ORBi
About statistics
About metrics
OAI-PMH
ORBi team
Release Notes
Back
Home
Detailled Reference
Request a copy
Letter to the editor (Scientific journals)
Reanalysis of death risk in long-term follow-up in infliximab patients versus controls
Fidder, H.
;
Van Steen, Kristel
;
Van Assche, G.
et al.
2010
•
In
Gut, 59
, p. 416
Peer Reviewed verified by ORBi
Permalink
https://hdl.handle.net/2268/38861
Files (1)
Send to
Details
Statistics
Bibliography
Similar publications
Files
Full Text
Response immortality.pdf
Author preprint (6.31 kB)
Request a copy
All documents in ORBi are protected by a
user license
.
Send to
RIS
BibTex
APA
Chicago
Permalink
X
Linkedin
copy to clipboard
copied
Details
Disciplines :
Gastroenterology & hepatology
Author, co-author :
Fidder, H.
Van Steen, Kristel
;
Université de Liège - ULiège > Dép. d'électric., électron. et informat. (Inst.Montefiore) > Bioinformatique
Van Assche, G.
Rutgeerts, P.
Vermeire, S.
Language :
English
Title :
Reanalysis of death risk in long-term follow-up in infliximab patients versus controls
Publication date :
2010
Journal title :
Gut
ISSN :
0017-5749
eISSN :
1468-3288
Publisher :
BMJ Group, London, United Kingdom
Volume :
59
Pages :
416
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 24 May 2010
Statistics
Number of views
50 (6 by ULiège)
Number of downloads
3 (1 by ULiège)
More statistics
Bibliography
Similar publications
Contact ORBi